Cutaneous decompression sickness | Canada Hyperbarics Skip to main content
Case Report Diving Hyperb Med 2014

Cutaneous decompression sickness

Tasios K, Sidiras G, Kalentzos V, Pyrpasopoulou A — Diving Hyperb Med, 2014

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported on a probable case of skin decompression sickness in a diver.

What They Found

They observed a diver with skin mottling (cutis marmorata) that improved within a few hours after receiving oxygen, intravenous methylprednisolone, and fluids, without immediate recompression. The patient received hyperbaric oxygen treatment approximately 10 hours after the dive. The authors noted that while skin decompression sickness itself isn't highly fatal, quick recognition is important as it could signal more serious issues.

Canadian Relevance

This study covers decompression sickness, which is a Health Canada-recognised indication for hyperbaric oxygen therapy. No direct Canadian connection was identified for the authors or study location.

Study Limitations

A key limitation is that this was a single case report, and an allergic reaction could not be entirely ruled out as the cause of the symptoms.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Case Report
Category Decompression Sickness
Source Pubmed
PubMed ID 24687485
Year Published 2014
Journal Diving Hyperb Med
MeSH Terms Decompression Sickness; Diving; Glucocorticoids; Humans; Hyperbaric Oxygenation; Male; Methylprednisolone; Middle Aged; Skin Diseases, Vascular

Cite This Study

Share

This study relates to Decompression Sickness. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Decompression Sickness

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology